T he importance of surveillance to controlling cancer is explicit. Guidelines for lifelong cancer risk management and prevention invariably comprise periodic medical evaluation and patient instruction about the value of adherence to follow-up guidelines. Another element of lifelong management is patient self-monitoring or self-surveillance. Although self-surveillance occurs out of the purview of clinicians, it plays a signifi cant role in lifelong health promotion and disease prevention. Patients who engage in self-surveillance interpret what they observe and decide to either self-treat, seek help, or avoid professional intervention. The observations and interpretations patients make of their physical signs and feelings are the sources of essential data that often are sought and used by clinicians to make medical judgments.
How patients think about the implications of their genetic predisposition and the meaning of lifelong surveillance for genetic risk of cancer affects their ability to accept and practice behaviors that promote health. Surveillance guidelines, however, do not elaborate on how, or the extent to which, patients should engage in self-surveillance activities. Although nurses, justifi ably, presume that self-surveillance may contribute to good health care, signifi cant gaps remain in the knowledge of patients' experiences. The purpose of this article is to describe the kinds of self-monitoring activities performed by patients with one of two types of cancer predisposition syndromes and the emotions associated with engaging in the self-surveillance activities. The This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org.
